These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10479795)

  • 21. Parkinson's disease. Signs of disease in fetal transplants.
    Miller G
    Science; 2008 Apr; 320(5873):167. PubMed ID: 18403684
    [No Abstract]   [Full Text] [Related]  

  • 22. Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.
    Büchele F; Döbrössy M; Hackl C; Jiang W; Papazoglou A; Nikkhah G
    Neurobiol Dis; 2014 Aug; 68():112-25. PubMed ID: 24780496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.
    Cisbani G; Freeman TB; Soulet D; Saint-Pierre M; Gagnon D; Parent M; Hauser RA; Barker RA; Cicchetti F
    Brain; 2013 Feb; 136(Pt 2):433-43. PubMed ID: 23378216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1.
    Kaemmerer WF; Low WC
    Exp Neurol; 1999 Aug; 158(2):301-11. PubMed ID: 10415138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 26. [Restoration of brain function by cell transplantation].
    Kakishita K; Nakao N; Itakura T
    Nihon Rinsho; 2003 Mar; 61(3):457-62. PubMed ID: 12701173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
    Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
    Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model.
    Björklund L; Spenger C; Strömberg I
    Exp Neurol; 1997 Nov; 148(1):324-33. PubMed ID: 9398475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation?
    Freed CR; Leehey MA; Zawada M; Bjugstad K; Thompson L; Breeze RE
    J Neurol; 2003 Oct; 250 Suppl 3():III44-6. PubMed ID: 14579124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural transplantation in Huntington disease: long-term grafts in two patients.
    Keene CD; Sonnen JA; Swanson PD; Kopyov O; Leverenz JB; Bird TD; Montine TJ
    Neurology; 2007 Jun; 68(24):2093-8. PubMed ID: 17562830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic approaches for the treatment of Huntington's disease.
    Mazurová Y
    Acta Medica (Hradec Kralove); 2001; 44(4):119-23. PubMed ID: 11836846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural transplantation: potential role in traumatic brain injury.
    Kanelos SK; McDeavitt JT
    J Head Trauma Rehabil; 1998 Dec; 13(6):1-9. PubMed ID: 9885314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
    Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
    J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal neural grafts for Huntington's disease: a prospective view.
    Bachoud-Lévi AC; Hantraye P; Peschanski M
    Mov Disord; 2002 May; 17(3):439-44. PubMed ID: 12112189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural transplantation for treatment of Parkinson's disease.
    Borlongan CV; Sanberg PR
    Drug Discov Today; 2002 Jun; 7(12):674-82. PubMed ID: 12110244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
    Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
    [No Abstract]   [Full Text] [Related]  

  • 37. Practical aspects of the use of human fetal brain tissue for intracerebral grafting.
    Brundin P; Björklund A; Lindvall O
    Prog Brain Res; 1990; 82():707-14. PubMed ID: 2290974
    [No Abstract]   [Full Text] [Related]  

  • 38. The cellular repair of the brain in Parkinson's disease--past, present and future.
    Sayles M; Jain M; Barker RA
    Transpl Immunol; 2004 Apr; 12(3-4):321-42. PubMed ID: 15157925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation.
    Rosenstein JM
    Exp Neurol; 1995 May; 133(1):1-6. PubMed ID: 7601258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transplantation of fetal dopaminergic cells in Parkinson disease].
    Zabek M; Mazurowski W; Dymecki J; Stelmachów J; Gawur B; Trautsolt W; Zawada E
    Neurol Neurochir Pol; 1992; Suppl 1():13-9. PubMed ID: 1407286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.